Annual Report Searches
Alphabetical Search

Advertisers


ALLERGAN PLC (AGN:NYSE)

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.


Yearly Figures
(in thousands, except per share amounts)
FYE: 12/31 2017 2016 2015 2014
Net Revenues $15,940,700 $14,570,600 $12,688,100 $6,738,900
Net Income $14,695,000 $3,683,200 ($1,630,500) ($750,400)
Earnings Per Share 38.18 10.01 (7.42) (5.27)
Quarterly Figures
(in thousands, except per share amounts)
              Third Quarter
FYE: 12/31 9/30/18 9/30/17
Net Revenues $3,911,400 $4,034,300
Net Income ($37,900) ($4,025,300)
Earnings Per Share (0.11) (12.07)
Contact Information
Contact Name: Lisa Defrancesco
Contact Title: Vice President, Global Investor Relations
Phone: 1-862-261-7152